<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib3">
 <label>3</label>
 <element-citation publication-type="journal" id="sbref30">
  <person-group person-group-type="author">
   <name>
    <surname>Simon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Peoch</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Casassus</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <article-title>Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95</article-title>
  <source>Br J Haematol</source>
  <volume>151</volume>
  <year>2010</year>
  <fpage>159</fpage>
  <lpage>166</lpage>
  <pub-id pub-id-type="pmid">20738307</pub-id>
 </element-citation>
</ref>
